Medications for Canine Atopic Dermatitis - Global and China Top Players Market Share and Ranking 2023
According to Latest Research, the global market for Medications for Canine Atopic Dermatitis should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Medications for Canine Atopic Dermatitis market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Medications for Canine Atopic Dermatitis market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Veterinary Hospital grew percent to account for percent of the total market sales, and Veterinary Clinic grew percent.
This report studies and analyses global Medications for Canine Atopic Dermatitis status and future trends, helps the client to determine the Medications for Canine Atopic Dermatitis market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Medications for Canine Atopic Dermatitis, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Medications for Canine Atopic Dermatitis market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Medications for Canine Atopic Dermatitis sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Medications for Canine Atopic Dermatitis sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Medications for Canine Atopic Dermatitis key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Medications for Canine Atopic Dermatitis key producing regions, capacity, production, and year over year growth
(6) Medications for Canine Atopic Dermatitis industry chains, upstream, midstream and downstream
Market segment by players, this report covers
GlenHaven
DermaPet
DVM Pharmaceuticals
Virbac
Enzo Life Sciences, Inc.
Pfizer Animal Health
Novartis Animal Health, Inc.
Eli Lilly and Company
Perrigo
Merck & Company
Zoetis Inc.
Toray Industries, Inc
Bayer Animal Health
Putney, Inc.
Dechra
Elanco
Kindred Biosciences
Nippon Zenyaku Kogyo Co., Ltd.
Market segment by Type, covers
Oral
External Use
Injection
Market segment by Application, can be divided into
Veterinary Hospital
Veterinary Clinic
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Medications for Canine Atopic Dermatitis product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Medications for Canine Atopic Dermatitis market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Medications for Canine Atopic Dermatitis market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Medications for Canine Atopic Dermatitis, percent & CAGR, 2018-2029
Chapter 5: Medications for Canine Atopic Dermatitis industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Medications for Canine Atopic Dermatitis Definition
1.2 Global Medications for Canine Atopic Dermatitis Market Size and Forecast
1.2.1 By Consumption Value, Global Medications for Canine Atopic Dermatitis Market Size，2018-2029
1.2.2 By Sales Quantity, Global Medications for Canine Atopic Dermatitis Market Size，2018-2029
1.2.3 Global Medications for Canine Atopic Dermatitis Average Selling Price (ASP)，2018-2029
1.3 China Medications for Canine Atopic Dermatitis Market Size and Forecast
1.3.1 By Consumption Value, China Medications for Canine Atopic Dermatitis Market Size，2018-2029
1.3.2 By Sales Quantity, China Medications for Canine Atopic Dermatitis Market Size，2018-2029
1.3.3 China Medications for Canine Atopic Dermatitis Average Selling Price (ASP)， 2018-2029
1.4 Share of China Medications for Canine Atopic Dermatitis Market with Respect to the Global Market
1.4.1 By Consumption Value, China Medications for Canine Atopic Dermatitis Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Medications for Canine Atopic Dermatitis Market Share in Global, 2018-2029
1.4.3 Medications for Canine Atopic Dermatitis Market Size: China VS Global, 2018-2029
1.5 Medications for Canine Atopic Dermatitis Market Dynamics
1.5.1 Medications for Canine Atopic Dermatitis Market Drivers
1.5.2 Medications for Canine Atopic Dermatitis Market Restraints
1.5.3 Medications for Canine Atopic Dermatitis Industry Trends
1.5.4 Medications for Canine Atopic Dermatitis Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Medications for Canine Atopic Dermatitis, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Medications for Canine Atopic Dermatitis, Global Market Share by Company, 2018-2023
2.3 Medications for Canine Atopic Dermatitis Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Medications for Canine Atopic Dermatitis Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Medications for Canine Atopic Dermatitis Concentration Ratio
2.6 Global Medications for Canine Atopic Dermatitis Mergers & Acquisitions, Expansion Plans
2.7 Global Medications for Canine Atopic Dermatitis Manufacturers Product Type
2.8 Head Office and Medications for Canine Atopic Dermatitis Production Site of Key Manufacturer
2.9 Medications for Canine Atopic Dermatitis Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Medications for Canine Atopic Dermatitis, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Medications for Canine Atopic Dermatitis, China Market Share by Company, 2018-2023
3.3 China Medications for Canine Atopic Dermatitis Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Medications for Canine Atopic Dermatitis Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Medications for Canine Atopic Dermatitis Capacity by Region
4.3 Global Medications for Canine Atopic Dermatitis Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Medications for Canine Atopic Dermatitis Production by Region, 2018-2029
4.5 Global Medications for Canine Atopic Dermatitis Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Medications for Canine Atopic Dermatitis Industry Chain
5.2 Medications for Canine Atopic Dermatitis Upstream Analysis
5.2.1 Medications for Canine Atopic Dermatitis Core Raw Materials
5.2.2 Main Manufacturers of Medications for Canine Atopic Dermatitis Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Medications for Canine Atopic Dermatitis Production Mode
5.6 Medications for Canine Atopic Dermatitis Procurement Model
5.7 Medications for Canine Atopic Dermatitis Industry Sales Model and Sales Channels
5.7.1 Medications for Canine Atopic Dermatitis Sales Model
5.7.2 Medications for Canine Atopic Dermatitis Typical Distributors
6 Sights by Type
6.1 Medications for Canine Atopic Dermatitis Classification
6.1.1 Oral
6.1.2 External Use
6.1.3 Injection
6.2 By Type, Global Medications for Canine Atopic Dermatitis Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Medications for Canine Atopic Dermatitis Consumption Value, 2018-2029
6.4 By Type, Global Medications for Canine Atopic Dermatitis Sales Quantity, 2018-2029
6.5 By Type, Global Medications for Canine Atopic Dermatitis Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Medications for Canine Atopic Dermatitis Segment by Application
7.1.1 Veterinary Hospital
7.1.2 Veterinary Clinic
7.2 By Application, Global Medications for Canine Atopic Dermatitis Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Medications for Canine Atopic Dermatitis Consumption Value, 2018-2029
7.4 By Application, Global Medications for Canine Atopic Dermatitis Sales Quantity, 2018-2029
7.5 By Application, Global Medications for Canine Atopic Dermatitis Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Medications for Canine Atopic Dermatitis Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Medications for Canine Atopic Dermatitis Consumption Value, 2018-2029
8.3 By Region, Global Medications for Canine Atopic Dermatitis Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Medications for Canine Atopic Dermatitis & Forecasts, 2018-2029
8.4.2 By Country, North America Medications for Canine Atopic Dermatitis Market Size Market Share
8.5 Europe
8.5.1 Europe Medications for Canine Atopic Dermatitis Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Medications for Canine Atopic Dermatitis Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Medications for Canine Atopic Dermatitis Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Medications for Canine Atopic Dermatitis Market Size Market Share
8.7 South America
8.7.1 South America Medications for Canine Atopic Dermatitis Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Medications for Canine Atopic Dermatitis Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Medications for Canine Atopic Dermatitis Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Medications for Canine Atopic Dermatitis Consumption Value, 2018-2029
9.3 By Country, Global Medications for Canine Atopic Dermatitis Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Medications for Canine Atopic Dermatitis Market Size, 2018-2029
9.4.2 By Type, U.S. Medications for Canine Atopic Dermatitis Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Medications for Canine Atopic Dermatitis Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Medications for Canine Atopic Dermatitis Market Size, 2018-2029
9.5.2 By Type, Europe Medications for Canine Atopic Dermatitis Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Medications for Canine Atopic Dermatitis Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Medications for Canine Atopic Dermatitis Market Size, 2018-2029
9.6.2 By Type, China Medications for Canine Atopic Dermatitis Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Medications for Canine Atopic Dermatitis Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Medications for Canine Atopic Dermatitis Market Size, 2018-2029
9.7.2 By Type, Japan Medications for Canine Atopic Dermatitis Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Medications for Canine Atopic Dermatitis Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Medications for Canine Atopic Dermatitis Market Size, 2018-2029
9.8.2 By Type, South Korea Medications for Canine Atopic Dermatitis Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Medications for Canine Atopic Dermatitis Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Medications for Canine Atopic Dermatitis Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Medications for Canine Atopic Dermatitis Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Medications for Canine Atopic Dermatitis Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Medications for Canine Atopic Dermatitis Market Size, 2018-2029
9.10.2 By Type, India Medications for Canine Atopic Dermatitis Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Medications for Canine Atopic Dermatitis Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Medications for Canine Atopic Dermatitis Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Medications for Canine Atopic Dermatitis Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Medications for Canine Atopic Dermatitis Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 GlenHaven
10.1.1 GlenHaven Company Information, Head Office, Market Area, and Industry Position
10.1.2 GlenHaven Medications for Canine Atopic Dermatitis Models, Specifications, and Application
10.1.3 GlenHaven Medications for Canine Atopic Dermatitis Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 GlenHaven Company Profile and Main Business
10.1.5 GlenHaven Recent Developments
10.2 DermaPet
10.2.1 DermaPet Company Information, Head Office, Market Area, and Industry Position
10.2.2 DermaPet Medications for Canine Atopic Dermatitis Models, Specifications, and Application
10.2.3 DermaPet Medications for Canine Atopic Dermatitis Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 DermaPet Company Profile and Main Business
10.2.5 DermaPet Recent Developments
10.3 DVM Pharmaceuticals
10.3.1 DVM Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.3.2 DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Models, Specifications, and Application
10.3.3 DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 DVM Pharmaceuticals Company Profile and Main Business
10.3.5 DVM Pharmaceuticals Recent Developments
10.4 Virbac
10.4.1 Virbac Company Information, Head Office, Market Area, and Industry Position
10.4.2 Virbac Medications for Canine Atopic Dermatitis Models, Specifications, and Application
10.4.3 Virbac Medications for Canine Atopic Dermatitis Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Virbac Company Profile and Main Business
10.4.5 Virbac Recent Developments
10.5 Enzo Life Sciences, Inc.
10.5.1 Enzo Life Sciences, Inc. Company Information, Head Office, Market Area, and Industry Position
10.5.2 Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Models, Specifications, and Application
10.5.3 Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Enzo Life Sciences, Inc. Company Profile and Main Business
10.5.5 Enzo Life Sciences, Inc. Recent Developments
10.6 Pfizer Animal Health
10.6.1 Pfizer Animal Health Company Information, Head Office, Market Area, and Industry Position
10.6.2 Pfizer Animal Health Medications for Canine Atopic Dermatitis Models, Specifications, and Application
10.6.3 Pfizer Animal Health Medications for Canine Atopic Dermatitis Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Pfizer Animal Health Company Profile and Main Business
10.6.5 Pfizer Animal Health Recent Developments
10.7 Novartis Animal Health, Inc.
10.7.1 Novartis Animal Health, Inc. Company Information, Head Office, Market Area, and Industry Position
10.7.2 Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Models, Specifications, and Application
10.7.3 Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Novartis Animal Health, Inc. Company Profile and Main Business
10.7.5 Novartis Animal Health, Inc. Recent Developments
10.8 Eli Lilly and Company
10.8.1 Eli Lilly and Company Company Information, Head Office, Market Area, and Industry Position
10.8.2 Eli Lilly and Company Medications for Canine Atopic Dermatitis Models, Specifications, and Application
10.8.3 Eli Lilly and Company Medications for Canine Atopic Dermatitis Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Eli Lilly and Company Company Profile and Main Business
10.8.5 Eli Lilly and Company Recent Developments
10.9 Perrigo
10.9.1 Perrigo Company Information, Head Office, Market Area, and Industry Position
10.9.2 Perrigo Medications for Canine Atopic Dermatitis Models, Specifications, and Application
10.9.3 Perrigo Medications for Canine Atopic Dermatitis Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Perrigo Company Profile and Main Business
10.9.5 Perrigo Recent Developments
10.10 Merck & Company
10.10.1 Merck & Company Company Information, Head Office, Market Area, and Industry Position
10.10.2 Merck & Company Medications for Canine Atopic Dermatitis Models, Specifications, and Application
10.10.3 Merck & Company Medications for Canine Atopic Dermatitis Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Merck & Company Company Profile and Main Business
10.10.5 Merck & Company Recent Developments
10.11 Zoetis Inc.
10.11.1 Zoetis Inc. Company Information, Head Office, Market Area, and Industry Position
10.11.2 Zoetis Inc. Medications for Canine Atopic Dermatitis Models, Specifications, and Application
10.11.3 Zoetis Inc. Medications for Canine Atopic Dermatitis Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Zoetis Inc. Company Profile and Main Business
10.11.5 Zoetis Inc. Recent Developments
10.12 Toray Industries, Inc
10.12.1 Toray Industries, Inc Company Information, Head Office, Market Area, and Industry Position
10.12.2 Toray Industries, Inc Medications for Canine Atopic Dermatitis Models, Specifications, and Application
10.12.3 Toray Industries, Inc Medications for Canine Atopic Dermatitis Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Toray Industries, Inc Company Profile and Main Business
10.12.5 Toray Industries, Inc Recent Developments
10.13 Bayer Animal Health
10.13.1 Bayer Animal Health Company Information, Head Office, Market Area, and Industry Position
10.13.2 Bayer Animal Health Medications for Canine Atopic Dermatitis Models, Specifications, and Application
10.13.3 Bayer Animal Health Medications for Canine Atopic Dermatitis Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Bayer Animal Health Company Profile and Main Business
10.13.5 Bayer Animal Health Recent Developments
10.14 Putney, Inc.
10.14.1 Putney, Inc. Company Information, Head Office, Market Area, and Industry Position
10.14.2 Putney, Inc. Medications for Canine Atopic Dermatitis Models, Specifications, and Application
10.14.3 Putney, Inc. Medications for Canine Atopic Dermatitis Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Putney, Inc. Company Profile and Main Business
10.14.5 Putney, Inc. Recent Developments
10.15 Dechra
10.15.1 Dechra Company Information, Head Office, Market Area, and Industry Position
10.15.2 Dechra Medications for Canine Atopic Dermatitis Models, Specifications, and Application
10.15.3 Dechra Medications for Canine Atopic Dermatitis Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Dechra Company Profile and Main Business
10.15.5 Dechra Recent Developments
10.16 Elanco
10.16.1 Elanco Company Information, Head Office, Market Area, and Industry Position
10.16.2 Elanco Medications for Canine Atopic Dermatitis Models, Specifications, and Application
10.16.3 Elanco Medications for Canine Atopic Dermatitis Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Elanco Company Profile and Main Business
10.16.5 Elanco Recent Developments
10.17 Kindred Biosciences
10.17.1 Kindred Biosciences Company Information, Head Office, Market Area, and Industry Position
10.17.2 Kindred Biosciences Medications for Canine Atopic Dermatitis Models, Specifications, and Application
10.17.3 Kindred Biosciences Medications for Canine Atopic Dermatitis Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.17.4 Kindred Biosciences Company Profile and Main Business
10.17.5 Kindred Biosciences Recent Developments
10.18 Nippon Zenyaku Kogyo Co., Ltd.
10.18.1 Nippon Zenyaku Kogyo Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
10.18.2 Nippon Zenyaku Kogyo Co., Ltd. Medications for Canine Atopic Dermatitis Models, Specifications, and Application
10.18.3 Nippon Zenyaku Kogyo Co., Ltd. Medications for Canine Atopic Dermatitis Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.18.4 Nippon Zenyaku Kogyo Co., Ltd. Company Profile and Main Business
10.18.5 Nippon Zenyaku Kogyo Co., Ltd. Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Medications for Canine Atopic Dermatitis Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Medications for Canine Atopic Dermatitis Market Restraints
Table 3. Medications for Canine Atopic Dermatitis Market Trends
Table 4. Medications for Canine Atopic Dermatitis Industry Policy
Table 5. Global Medications for Canine Atopic Dermatitis Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Medications for Canine Atopic Dermatitis Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Medications for Canine Atopic Dermatitis Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Medications for Canine Atopic Dermatitis Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Medications for Canine Atopic Dermatitis Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Medications for Canine Atopic Dermatitis Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Medications for Canine Atopic Dermatitis Mergers & Acquisitions, Expansion Plans
Table 12. Global Medications for Canine Atopic Dermatitis Manufacturers Product Type
Table 13. Head Office and Medications for Canine Atopic Dermatitis Production Site of Key Manufacturer
Table 14. Medications for Canine Atopic Dermatitis Capacity of Major Manufacturers and Future Plan
Table 15. China Medications for Canine Atopic Dermatitis Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Medications for Canine Atopic Dermatitis Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Medications for Canine Atopic Dermatitis Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Medications for Canine Atopic Dermatitis Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Medications for Canine Atopic Dermatitis Production by Region, 2018-2023, (K Units)
Table 20. Global Medications for Canine Atopic Dermatitis Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Medications for Canine Atopic Dermatitis Upstream (Raw Materials)
Table 22. Global Medications for Canine Atopic Dermatitis Typical Customers
Table 23. Medications for Canine Atopic Dermatitis Typical Distributors
Table 24. By Type, Global Medications for Canine Atopic Dermatitis Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Medications for Canine Atopic Dermatitis Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Medications for Canine Atopic Dermatitis Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Medications for Canine Atopic Dermatitis Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Medications for Canine Atopic Dermatitis Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Medications for Canine Atopic Dermatitis Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Medications for Canine Atopic Dermatitis Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Medications for Canine Atopic Dermatitis Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Medications for Canine Atopic Dermatitis Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Medications for Canine Atopic Dermatitis Sales Quantity Market Share, 2018-2029
Table 34. GlenHaven Company Information, Head Office, Market Area, and Industry Position
Table 35. GlenHaven Medications for Canine Atopic Dermatitis Models, Specifications, and Application
Table 36. GlenHaven Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. GlenHaven Company Profile and Main Business
Table 38. GlenHaven Recent Developments
Table 39. DermaPet Company Information, Head Office, Market Area, and Industry Position
Table 40. DermaPet Medications for Canine Atopic Dermatitis Models, Specifications, and Application
Table 41. DermaPet Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. DermaPet Company Profile and Main Business
Table 43. DermaPet Recent Developments
Table 44. DVM Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 45. DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Models, Specifications, and Application
Table 46. DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. DVM Pharmaceuticals Company Profile and Main Business
Table 48. DVM Pharmaceuticals Recent Developments
Table 49. Virbac Company Information, Head Office, Market Area, and Industry Position
Table 50. Virbac Medications for Canine Atopic Dermatitis Models, Specifications, and Application
Table 51. Virbac Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Virbac Company Profile and Main Business
Table 53. Virbac Recent Developments
Table 54. Enzo Life Sciences, Inc. Company Information, Head Office, Market Area, and Industry Position
Table 55. Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Models, Specifications, and Application
Table 56. Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Enzo Life Sciences, Inc. Company Profile and Main Business
Table 58. Enzo Life Sciences, Inc. Recent Developments
Table 59. Pfizer Animal Health Company Information, Head Office, Market Area, and Industry Position
Table 60. Pfizer Animal Health Medications for Canine Atopic Dermatitis Models, Specifications, and Application
Table 61. Pfizer Animal Health Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Pfizer Animal Health Company Profile and Main Business
Table 63. Pfizer Animal Health Recent Developments
Table 64. Novartis Animal Health, Inc. Company Information, Head Office, Market Area, and Industry Position
Table 65. Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Models, Specifications, and Application
Table 66. Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Novartis Animal Health, Inc. Company Profile and Main Business
Table 68. Novartis Animal Health, Inc. Recent Developments
Table 69. Eli Lilly and Company Company Information, Head Office, Market Area, and Industry Position
Table 70. Eli Lilly and Company Medications for Canine Atopic Dermatitis Models, Specifications, and Application
Table 71. Eli Lilly and Company Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Eli Lilly and Company Company Profile and Main Business
Table 73. Eli Lilly and Company Recent Developments
Table 74. Perrigo Company Information, Head Office, Market Area, and Industry Position
Table 75. Perrigo Medications for Canine Atopic Dermatitis Models, Specifications, and Application
Table 76. Perrigo Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Perrigo Company Profile and Main Business
Table 78. Perrigo Recent Developments
Table 79. Merck & Company Company Information, Head Office, Market Area, and Industry Position
Table 80. Merck & Company Medications for Canine Atopic Dermatitis Models, Specifications, and Application
Table 81. Merck & Company Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Merck & Company Company Profile and Main Business
Table 83. Merck & Company Recent Developments
Table 84. Zoetis Inc. Company Information, Head Office, Market Area, and Industry Position
Table 85. Zoetis Inc. Medications for Canine Atopic Dermatitis Models, Specifications, and Application
Table 86. Zoetis Inc. Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Zoetis Inc. Company Profile and Main Business
Table 88. Zoetis Inc. Recent Developments
Table 89. Toray Industries, Inc Company Information, Head Office, Market Area, and Industry Position
Table 90. Toray Industries, Inc Medications for Canine Atopic Dermatitis Models, Specifications, and Application
Table 91. Toray Industries, Inc Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Toray Industries, Inc Company Profile and Main Business
Table 93. Toray Industries, Inc Recent Developments
Table 94. Bayer Animal Health Company Information, Head Office, Market Area, and Industry Position
Table 95. Bayer Animal Health Medications for Canine Atopic Dermatitis Models, Specifications, and Application
Table 96. Bayer Animal Health Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Bayer Animal Health Company Profile and Main Business
Table 98. Bayer Animal Health Recent Developments
Table 99. Putney, Inc. Company Information, Head Office, Market Area, and Industry Position
Table 100. Putney, Inc. Medications for Canine Atopic Dermatitis Models, Specifications, and Application
Table 101. Putney, Inc. Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Putney, Inc. Company Profile and Main Business
Table 103. Putney, Inc. Recent Developments
Table 104. Dechra Company Information, Head Office, Market Area, and Industry Position
Table 105. Dechra Medications for Canine Atopic Dermatitis Models, Specifications, and Application
Table 106. Dechra Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Dechra Company Profile and Main Business
Table 108. Dechra Recent Developments
Table 109. Elanco Company Information, Head Office, Market Area, and Industry Position
Table 110. Elanco Medications for Canine Atopic Dermatitis Models, Specifications, and Application
Table 111. Elanco Medications for Canine Atopic Dermatitis Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Elanco Company Profile and Main Business
Table 113. Elanco Recent Developments
Table 114. Kindred Biosciences Company Information, Head Office, Ma
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|